Abstract
In assessing quality of life, the question arises which measurement strategy is most appropriate in a given clinical trials situation. Choices may pertain to the inclusion of generic versus disease-specific instruments, to patient self-ratings versus expert ratings or to the administration interviews versus questionnaires1,10. Of special importance for the type of data gathered is the decision between the use of indices versus profiles for the assessment of quality of life. This decision requires a reflection on the conceptual, methodological and practical issues involved in making such a choice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson, N.C. Quality of life assessment in clinical trials: methodologic issues. Contr. Clin. Trials 1989; 10: 1955–2085.
Aaronson, N.K., Bullinger, M. and Ahmedzai, S. A modular approach to quality of life in cancer clinical trials. Rec. Res. Cancer Res. 1988; 111: 231–249.
Berg, R.L. Health Status Indices. Hospital Research and Educational Trust, Chicago, 1973.
Bergner, M., Bobbit, R.A., Carter, W.B. and Gilson, B.S. The sickness impact profile. Development and final revision of a health status measure. Med. Care 1981; 19: 787–805.
Bullinger, M. and Hasford, J. Testing and evaluating quality of life measures for German clinical trials. Contr. Clin. Trials 1991; 12: 915–1055.
Bullinger, M., Heinisch, M., Ludwig, M. and Geier, S. Skalen zur Ferfassung des Wohlbefindens. Psychometrische iiberpriifung des Profile of Mood States (POMS).Z. Diff. Diag. Psychol. 1990; 11: 53–61.
Croog, S.H., Levine, S., Testa, M.A. et. al. The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 1986; 314: 1657–1664.
DuPuy, H.J. The Psychological General Well-Being (PGWB) index. In Wenger, N.K., Mattson, M.E., Furberg, C.D. and Ellinson, J. (eds). Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, LeJacq Publishers, 1984, pp. 170–183.
Feinstein, A.R. et. al. Scientific and clinical problems in indices of functional disability. Ann. Intern. Med. 1986; 105: 413–420.
Guyatt, G.H. and Jaeschke, R. Measurement in clinical trials-choosing the appropriate approach. In Spilker, B. (ed.) Quality of Life Assessment in Clinical Trials. New York, Raven Press, 1990, pp. 37–46.
Guyatt, G., Walter, S. and Norman, G. Measuring change over time-assessing the usefulness of evaluative instruments. J. Chronic Dis. 1987; 40: 171–178.
Hunt, S. The Nottingham Health Profile. In Wenger, N.K., Mattson, M.E., Furberg, C.D. and Ellinson, J. (eds) Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, LeJacq Publishers, 1984.
Kaplan, R.M., Bush, J.W. and Berry, C.C. Health status: types of validity and the index of well-being. Health Serv. Res. 1976; 11: 478–507.
Kaplan, R. and Stewart, L. Pros and cons of single vs. multi outcome quality of life assessments. In Shumaker, S.A. and Furber, C. (eds). Research on Quality of Life and Cardiovascular Disease. Am. J. Prevent. Med. (in press).
Kirshner, B. and Guyatt, G. A methodological framework for assessing health indices. J. Chronic Dis. 1985; 38: 27–36.
McDowell, I. and Newell, C. Measuring Health: A Guide to Rating Scales and Questionnaires. New York, Oxford University Press, 1987.
McNair, D., Lorr, M. and Droppelman, L.F. Manual for the Profile of Mood States. California, Educational and Industrial Testing Service, San Diego, 1971.
Olschewski, M. and Schumacher, M. Statistical analysis of quality of life data in cancer clinical trials. Stat. Med. 1990; 9: 749–763.
Patrick, D.L. and Erickson, P. Assessing health-related quality of life for clinical decision making. In Walker, S.R. and Rosser, R.M. (eds). Quality of Life: Assessment and Application. Lancaster, MTP Press, 1988, pp. 183–197.
Pocock, S.J., Geller, N.L. and Tsiatis, A.A. The analysis of multiple endpoints in clinical trials. Biometrics 1987; 43: 487–498.
Spilker, H. Quality of Life Assessment in Clinical Trials. New York, Raven Press, 1990.
Spitzer, W.Q., Dobson, A.J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., Battista, R.N. and Catchlove, B.R. Measuring the quality of life of cancer patients. A concise QL-Index for use by physicians. J. Chronic Dis. 1981; 34: 585–597.
Streiner, D.L. and Normann, G. Health Measurement Scales-a Practical Guide to their Development and Use. Oxford, Oxford University Press, 1989.
Tandon, P. Applications of global statistics in analysing quality of life data. Stat. Med. 1990; 9: 819–827.
Walker, S.R. and Rosser, R.M. Quality of Life Assessment and Application. Lancaster, MTP Press, 1988.
Ware, J.E. Standards for validating health measures; Definition and content. J. Chronic Dis. 1987; 40: 503–512.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Bullinger, M. (1993). Indices versus profiles — advantages and disadvantages. In: Walker, S.R., Rosser, R.M. (eds) Quality of Life Assessment: Key Issues in the 1990s. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2988-6_12
Download citation
DOI: https://doi.org/10.1007/978-94-011-2988-6_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5328-0
Online ISBN: 978-94-011-2988-6
eBook Packages: Springer Book Archive